期刊文献+

甲地孕酮对小细胞肺癌EP方案化疗患者生活质量改善的研究 被引量:1

Study of the Improvement of Quallity of Life by Megestrol Acetate in Patients with Small Cell Lung Cancer by EP Regimen
暂未订购
导出
摘要 目的观察甲地孕酮(MA)对EP方案治疗小细胞肺癌患者生活质量的影响。方法 67例小细胞肺癌患者随机分成治疗组和对照组,所有患者均给予EP方案化疗,其中治疗组同时给予MA口服治疗,观察并记录患者治疗前后KPS评分、食欲、体重及睡眠变化情况。结果治疗组化疗后KPS评分升高4,而对照组降低了10,两组间KPS评分在化疗后比较有显著性差异(P<0.05);治疗组化疗后食欲增加者占82.3%(28/34),对照组食欲增加者占6.1%(2/33),两组间比较有显著性差异(P<0.05);治疗组化疗后体重增加者占70.6%(24/34),对照组体重增加者占9.1%(3/33),两组间比较有显著性差异(P<0.05);治疗组化疗后睡眠好者占50%(17/34),对照组睡眠好者占18.2%(6/33),两组间比较有显著性差异(P<0.05)。结论甲地孕酮能明显提高EP方案化疗小细胞肺癌患者的生活质量,值得临床推广应用。 Objective To investigate the effect of megestrol acetate(MA) to improve the quality of life in patients with small cell lung cancer treated by EP regimen. Methods 67 cases with small cell lung cancer were randomly divided into two groups: 34 cases in treatment group(MA+EP) and 33 cases in control group(EP).the change of KPS,appetite,body weight and sleep in each group after treatment were observed. Results In KPS there was no significant difference between two groups before chemotherapy,while significant difference were shown with 4 rising in treatment group and-10 increased in control group after the treatment.Significant statistical difference(P0.05) was shown with 14.6 more in the former than the latter in KPS.Obvious improvements(P0.05) were also shown in the member of appetite improved in 82.3%(28/34),body weight increased in 70.6%(24/34) and better sleep in 50%(17/34) in treatment group,compared with 6.1%(2/33),9.1%(3/33),and 18.2%(6/33) in control group after chemotherapy in statistics. Conclusion Megestrol acetate can significantly improve the quality of life in patients with small cell lung cancer treated by EP regimen.
出处 《河南科技大学学报(医学版)》 2011年第1期42-44,共3页 Journal of Henan University of Science & Technology:Medical Science
关键词 甲地孕酮 化疗 小细胞肺癌 生活质量 megestrol acetate chemotherapy small cell lung cancer quality of life
  • 相关文献

参考文献8

  • 1谢忠,谢杰荣,温继育,冯丽萍.TP方案联合香菇多糖或甲地孕酮治疗晚期非小细胞肺癌[J].中国肿瘤,2006,15(3):199-202. 被引量:12
  • 2王金万,张频,王宏羽,何小慧,谢雅莉,董梅,周际昌,王奇璐,冯奉仪,孙燕.甲孕酮改善化疗患者厌食、体重下降及骨髓抑制作用的临床观察[J].中华肿瘤杂志,1995,17(4):283-285. 被引量:65
  • 3Ruiz GV, Juan O, Pcreez HS, et al. Megestrol acetate: a systematic review usefulness about the weight gain in neoplastic patients with cachexia [ J ]. Med Clin (Barc ), 2002,119 ( 5 ) : 166 - 170.
  • 4Khuri FR, Fossella FV, Lee JS, et al. Phase II trial of recombinant IFN-alpha2a with etoposide cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer[J]. Interferon Cytokine Res,1998,18(4):241 -245.
  • 5Navari RM, Brenner MC. Treatment of cancer-related anorexia with olanzapine and megestrol acetate [ J ]. A randomized trial. Support Care Cancer,2010,18(8) :951 - 956.
  • 6Ulutin HC, Arpaci F, Pak Y. Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer:a randomized study comparing two different doses[ J]. Tumori ,2002,88 ( 4 ) : 277 -280.
  • 7Licchetta A, Correale P, Migali C, et al. Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate [ J ]. Chemother, 2010,22 (3) :201 -204.
  • 8Busquets S, Serpe R, Sirisi S, et al. Megestrol acetate :its impact on muscle protein metabolism supports its use in cancer cachexia[J]. Clin Nutr,2010 ,29(6) :733 -737.

二级参考文献9

共引文献72

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部